Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: Strategic Partnerships Driving Innovation In Opioid-Induced Constipation Treatment

The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period?
The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.0%. The market's growth in recent years is driven by factors such as the aging population, personalized OIC treatments, availability of effective drugs, rising opioid use, and the growing incidence of gastrointestinal disorders.

The opioid-induced constipation treatment market is forecasted to reach $2.47 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. The expected growth is driven by fast-tracked drug approvals, an increase in opioid analgesic prescriptions, a surge in research and development for new treatments, and the development of biologics. Key trends include growing patient awareness, the rise of targeted therapies, non-pharmacological interventions, biotech innovations, and more investments in the sector.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15881

What Are the High-Growth Segments in the Opioid-Induced Constipation Treatment Market?
The opioid-induced constipation treatment market covered in this report is segmented -

1) By Drug Class: Laxatives, Peripherally Acting ?-opioid Receptor Antagonists, Serotonin Receptor Agonists, Prostaglandin
2) By Type: Oral, Parenteral
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:
1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives
2) By Peripherally Acting ?-Opioid Receptor Antagonists: Naloxegol, Methylnaltrexone, Alvimopan
3) By Serotonin Receptor Agonists: Prucalopride, Tegaserod
4) By Prostaglandin: Lubiprostone

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15881&type=smp

What Key Drivers Are Expected to Influence Future Opioid-Induced Constipation Treatment Market Growth?
The growth of the opioid-induced constipation treatment market is expected to accelerate due to the increased use of opioids for managing cancer and non-cancer pain. This pain management strategy is driven by the need to address moderate to severe pain while balancing the risks of addiction and side effects. Opioid-induced constipation treatment helps alleviate constipation caused by opioids, improving patients' comfort and adherence to pain management regimens. For example, a report from the Government of Canada in May 2021 estimated that up to 8.3 million Canadians might experience chronic pain by 2025, with that number rising to 9 million by 2030, further contributing to the market's growth.

Which Companies Hold the Largest Share Across Different Opioid-Induced Constipation Treatment Market Segments?
Major companies operating in the opioid-induced constipation treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc., Valinor Pharma LLC

What Are the Latest Developing Trends in the Opioid-Induced Constipation Treatment Market?
Major players in the opioid-induced constipation treatment market are entering into strategic partnerships to drive the development of new medications. These collaborations allow companies to pool their resources and expertise, improving their R&D capabilities, increasing their market presence, speeding up commercialization, and ultimately promoting innovation and industry growth. For example, in November 2022, Japan-based Kyowa Kirin Co. Ltd joined forces with Germany-based Grünenthal GmbH to strengthen patient care solutions. This partnership aims to boost the global availability and growth of a portfolio of important pain management therapies, including those for opioid-induced constipation, breakthrough cancer pain, and osteoporosis.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

What Are the Emerging Geographies for The Opioid-Induced Constipation Treatment Market Growth?
North America was the largest region in the opioid-induced constipation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioid-induced constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Opioid-Induced Constipation Treatment Market?
2. What is the CAGR expected in the Opioid-Induced Constipation Treatment Market?
3. What Are the Key Innovations Transforming the Opioid-Induced Constipation Treatment Industry?
4. Which Region Is Leading the Opioid-Induced Constipation Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.